Georgia Medical Marijuana License

Medical Georgia Cannabis License

By /

Estimated reading time: 4 minutes

Table of contents

Medical Georgia Cannabis License

In 2015, Georgia approved Haleigh’s Hope Act – a highly restrictive medical cannabis bill that permits patients with approved serious medical conditions to use medicinal cannabis. However, the medical cannabis bill only allows patients to use cannabis oil with a maximum of five percent THC, and it does not permit buying, selling, or transporting the oil. In 2019, Georgia’s General Assembly passed legislation that legalized licensed cannabis cultivation in Georgia and the conversion of the leaf into cannabis oil and the retail sale to eligible patients. A recent decision by the Georgia Access to Medical Cannabis Commission will propel Georgia’s medical cannabis industry forward.

On Nov. 23, 2020, the Commission voted to release a Request for Proposals (RFP) that opens up the licensing process for businesses seeking to cultivate and manufacture low-THC cannabis oil. The state will issue six total production licenses – two “Class 1” licenses and four “Class 2” licenses for indoor cultivation and manufacturing. Class 1 licenses are permitted to operate in up to 100,000 square feet of space, whereas Class 2 licensees will be limited to 50,000 square feet. Deadlines are fast approaching as applicants have until Dec. 28 at 2 PM EST to apply.

Class 1 applications require a $25,000 non-refundable application fee along with a $200,000 licensing fee and a $100,00 annual renewal fee. Class 2 applications require a $5,000 non-refundable application fee, along with an initial $100,000 licensing fee and a $50,000 annual renewal fee. In addition to application fees, applications must have a large cash bond payable to Georgia or an irrevocable line of credit issued within 30 days of licensure. For Class 1 licenses, the amount is $1.5 million, and for Class 2 licenses, the amount is $625,000. Once licensed, a business will have one year to become operational or their license can be revoked. Applications and information about the application process can be found on the GA Access to Medical Cannabis Commission website.

Although Georgia’s medical cannabis program has taken a long time to develop and only has 14,000 registered patients, the application and licensing process is expected to be highly competitive and nuanced. Many entrepreneurs expect Georgia’s medical cannabis program to mature and become more progressive over time, eventually leading to a recreational cannabis market. The early bird gets the worm. Should this scenario play out, early licensees will likely have a significant competitive advantage in being first to market in a brand-new and highly lucrative industry.

Licenses are expected to be issued by March 2021. Once businesses are licensed to operate, it can take up to six months or longer before oil may become accessible to patients. Applications for dispensary licenses are not yet available. The long-term future of cannabis in Georgia remains hazy; however, the immediate future is prosperous. The Dec. 28 deadline is approaching quickly! It’s not too late. If you need last-minute support, subject matter expertise, facility design, board representation, or other assistance with the application process, contact us today!

Andy is an Operations Advisor at Catalyst BC.   

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

  • An Owner's Rep for Cannabis Dispensary Buildout examines blueprints, ensuring compliance and project accuracy.
    The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
    In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase.
  • Modern New Jersey cannabis lounge interior design
    Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
    As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City.
  • Modern interior of a licensed New York cannabis lounge
    New York Cannabis Lounge License: Expert Guide to Compliance and Success
    The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation.
  • A large-scale, brightly lit commercial cannabis greenhouse in New York featuring rows of healthy cannabis plants under advanced LED grow lights.
    The 2026 New York Execution Gap: Scaling Your Cannabis Business
    The trajectory of the New York cannabis industry has transitioned from a period of experimental regulation to one of massive commercial consolidation and operational intensity. As of April 15, 2026, the state has officially matured into its role as the second-largest cannabis market in the United States, trailing only California in total economic activity and consumer demand. The primary indicator of this success is the milestone reached in early 2026, where total reported retail sales since the inception of the legal program surpassed $2.97 billion.
  • Close-up view of a cannabis flower with intricate trichomes, highlighting insights on New Jersey Cannabis Legalization and New Jersey Cannabis Laws.
    Regulatory Maturity and Market Dynamics: A Comprehensive Analysis of the New Jersey Cannabis Industry
    The legal landscape of cannabis in New Jersey has transitioned from a period of rapid legislative enactment into an era of complex regulatory maturity and secondary market correction. Since the foundational passage of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) in early 2021, the state has systematically dismantled the architecture of prohibition while constructing a highly regulated, billion-dollar industry.
  • A high-tech, pharmaceutical-grade indoor cannabis cultivation facility in Nebraska designed for precision production under the state's strict 1,250-plant limit.
    Nebraska Medical Cannabis Market Strategic Report: Navigating the Regulatory Landscape and Licensing Framework 2026
    The Nebraska medical cannabis industry has undergone a radical transformation from its nascent beginnings in the 2024 general election to the highly structured, albeit restrictive, regulatory environment of April 2026. This period has been characterized by intense legislative maneuvering, high-stakes licensing competitions, and a fundamental shift in the state’s administrative approach to controlled substances.

Explore Our Articles

cannabis applications Cannabis Bar Cannabis Business Optmization cannabis careers Cannabis Compliance Cannabis Consumption Cannabis Consumption Bar Cannabis Inventory Management Systems Cannabis Investors cannabis jobs Cannabis Legalization cannabis licensing Cannabis Lounge cannabis marketing Cannabis Operational Procedures cannabis outreach Cannabis Regulations Cannabis Security Cannabis Software Cannabis Startup Cannabis Supply Chain Cannabis Technology Colorado controlled environment agriculture Cultivation cultivation facility Dispensary Design facility design Financial Planning HVAC HVACD Iowa Kansas Legal Update Legislation Medical Cannabis Minnesota Natural Medicine Nebraska New York Odor Control Oregon Psilocybin Psychedelics Recreational Cannabis

Scroll to Top